Ifp Advisors, Inc Pacira Bio Sciences, Inc. Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 670 shares of PCRX stock, worth $11,758. This represents 0.0% of its overall portfolio holdings.

Number of Shares

670

Previous 670 -0.0%

Holding current value

$11,758

Previous $19,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jul 30, 2024	SELL	$27.7 - $35.48 $1,385 - $1,773	-50 Reduced 6.94%	670 $19,000
Q4 2023 Jan 09, 2024	BUY	$26.32 - $34.31 $658 - $857	25 Added 3.6%	720 $24,000
Q1 2023 Apr 18, 2023	SELL	$35.53 - $43.38 $1,456 - $1,778	-41 Reduced 5.57%	695 $28,000
Q4 2022 Feb 07, 2023	SELL	$38.19 - $57.45 $7,332 - $11,030	-192 Reduced 20.69%	736 $26,000
Q3 2022 Nov 08, 2022	BUY	$51.24 - $58.89 $563 - $647	11 Added 1.2%	928 $36,000
Q2 2022 Sep 06, 2022	BUY	$51.49 - $81.64 $47,216 - $74,863	917 New	917 $36,000
Q2 2022 Aug 12, 2022	SELL	$51.49 - $81.64 $47,216 - $74,863	-917 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$60.03 - $76.49 $13,326 - $16,980	222 Added 31.94%	917 $69,000
Q3 2021 Oct 06, 2021	BUY	$54.64 - $61.3 $36,608 - $41,071	670 Added 2680.0%	695 $39,000
Q1 2021 Apr 30, 2021	SELL	$59.31 - $78.82 $7,473 - $9,931	-126 Reduced 83.44%	25 $2,000
Q4 2020 Jan 25, 2021	SELL	$50.47 - $66.26 $60,917 - $79,975	-1,207 Reduced 88.88%	151 $9,000
Q3 2020 Oct 29, 2020	BUY	$51.97 - $63.0 $70,575 - $85,554	1,358 New	1,358 $81,000
Q2 2020 Aug 05, 2020	BUY	$30.8 - $52.47 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	SELL	$36.47 - $42.17 $7,294 - $8,434	-200 Closed	0 $0
Q4 2018 Jan 23, 2019	BUY	$41.31 - $52.16 $4,131 - $5,216	100 Added 100.0%	200 $8,000
Q4 2016 Jun 03, 2019	SELL	N/A	-11 Reduced 9.91%	100 $3,000
Q2 2016 Jun 03, 2019	BUY	N/A	111	111 $4,000

Others Institutions Holding PCRX

# of Institutions

264

Shares Held

50.6M

Call Options Held

429K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $804M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account